Bank of Kentucky’s Allergan plc AGN Stock Holding History

Bank of Kentucky’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	$6K	Hold	19	–	–	﹤0.01%	251
2014 Q4	$5K	Buy	+19	New	+$4.75K	﹤0.01%	275

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Bank of Kentucky's AGN Position: Q1 2015 in Review

Bank of Kentucky held its Allergan plc (AGN) position steady in Q1 2015 at 19 shares worth $6K. The position accounts for ﹤0.01% of the portfolio, ranked #251.

Bank of Kentucky first reported a position in AGN in Q4 2014 and has held it in 2 quarters since. 1,089 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Bank of Kentucky held 19 shares of Allergan plc worth $6K as of Q1 2015.
Bank of Kentucky left its Allergan plc share count unchanged in Q1 2015.
Allergan plc made up ﹤0.01% of Bank of Kentucky's portfolio in Q1 2015, its #251 holding.
Bank of Kentucky first reported a position in Allergan plc in Q4 2014 and has held it in 2 quarters since.
1,089 funds tracked by Wall St. Rank held Allergan plc as of Q1 2015.

Based on Bank of Kentucky's 13F filing for Q1 2015, filed 28 Apr 2015.